Cytokeratin-18 is a sensitive biomarker of alanine transaminase increase in a placebo-controlled, randomized, crossover trial of therapeutic paracetamol dosing (PATH-BP biomarker substudy). (2024)

First Author: Scullion KM
Attributed to:  MICA: Point-of-care assessment of drug-induced liver injury (POC-DILI) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/toxsci/kfae031

PubMed Identifier: 38521541

Publication URI: http://europepmc.org/abstract/MED/38521541

Type: Journal Article/Review

Volume: 199

Parent Publication: Toxicological sciences : an official journal of the Society of Toxicology

Issue: 2

ISSN: 1096-0929